Gadoth, Avi
Devine, Michelle F.
Pittock, Sean J.
McKeon, Andrew
Tobin, W. Oliver
Gossard, Thomas R.
Cattaneo, Elena F. D.
McCarter, Stuart J.
St. Louis, Erik K. http://orcid.org/0000-0002-2833-8826
Funding for this research was provided by:
National Center for Advancing Translational Sciences (UL1 Tr002377)
National Institute on Aging (R34 AG056639)
Article History
Received: 6 January 2023
Revised: 29 March 2023
Accepted: 30 March 2023
First Online: 7 April 2023
Declarations
:
: The following authors have nothing to disclose: Gadoth, McCarter, Gossard, Cattaneo, Devine. Non-financial Interests: S.J. Pittock has provided consultation to Alexion Pharmaceuticals and MedImmune but has received no personal fees or personal compensation for these consulting activities. A. McKeon has consulted for MedImmune, LLC, Grifols and Euroimmun but has not received personal compensation for these activities. E. St. Louis has consulted for Axovant, Inc., but has not received personal compensation for these activities. Financial Interests: S. J. Pittock has received research support from Alexion Pharmaceuticals, MedImmune and Grifols. W. O. Tobin receives research support from the National Institute of Neurological Disorders and Stroke, the National Institute of Allergy and Infectious Diseases, Alexion Pharmaceuticals, Sanofi US Services Inc., and UCB Biosciences. A. McKeon receives research support from MedImmune, LLC. E. St. Louis receives research support from the National Center for Advancing Translational Sciences, the National Institute of Neurological Disorders and Stroke, the National Heart, Lung and Blood Institute, Axovant, Inc., and Sunovion, Inc.